Published April 2008 | Version v1
Journal article

High incidence of AML1 point mutations in myelodysplastic syndrome among residents of the area near the Semipalatinsk nuclear explosion test site

  • 1. Hiroshima Univ., Research Inst. for Radiation Biology and Medicine, Hiroshima, Hiroshima (Japan)
  • 2. Kazakh Scientific Research Inst. for Radiation Medicine and Ecology (Kazakhstan)
  • 3. Semipalatinsk State Medical Academy (Kazakhstan)

Description

no abstract available

Additional details

Publishing Information

Journal Title
Hiroshima Igaku
Journal Volume
61
Journal Issue
4
Journal Page Range
p. 357-359
ISSN
0367-5904

Conference

Title
48. research meeting on aftereffects of exposure to radiation by atomic bombs
Dates
3 Jun 2007
Place
Hiroshima (Japan)